This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Steven Thomas Staben: Innovator in Therapeutic Compounds
Introduction
Steven Thomas Staben is an accomplished inventor based in South San Francisco, CA (US). He has made significant contributions to the field of therapeutic compounds, particularly in the development of treatments for serious diseases.
Latest Patents
Staben holds a patent for "Therapeutic compounds and methods." This invention provides a compound of formula (I) or a prodrug thereof, or a pharmaceutically acceptable salt thereof. The compounds are agonists of the glycolytic enzyme phosphofructokinase-1 liver type and are useful for treating diseases associated with this enzyme's activity, such as cancer, diabetes, sepsis, and septic shock. He has 1 patent to his name.
Career Highlights
Staben is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His work focuses on developing novel therapeutic strategies that can significantly impact patient care.
Collaborations
Throughout his career, Staben has collaborated with notable colleagues, including Elisia Villemure and Vishva M Dixit. These collaborations have contributed to the advancement of research in therapeutic compounds.
Conclusion
Steven Thomas Staben is a notable inventor whose work in therapeutic compounds has the potential to transform treatment options for various diseases. His contributions to the field highlight the importance of innovation in healthcare.